Workshop Six Reading Read the following selections in Pharmacotherapeutics for Advanced Practice

Workshop Six Reading
Read the following selections in Pharmacotherapeutics for Advanced Practice Nurses and Physicians Assistants:
Local Anesthetics (Chapter 23)
Basic Pharmacology of local anesthetics, p. 179-81, Tables 23.1-3
Properties of individual local anesthetics, p. 181
Clinical use of local anesthetics, p. 181-82
Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting Analgesics (Chapter 24)
Opioid analgesics, p. 183, Tables 24.1-2
Basic pharmacology of the opioids, p. 183-90, Tables 24.3-10
Opioid antagonists, p. 190-91
Nonopioid centrally acting analgesic – tramadol, p. 191
Prescribing opioids for chronic, noncancer pain during a national opioid crisis, p. 191-94, Box 24.1, Table 24.11
Drugs for Muscle Spasm and Spasticity (Chapter 22)
Drugs for spasticity, p. 171-75, Tables 22.1-2
Drugs for localized muscle spasm, p.175
Cyclobenzaprine, p. 175-6
Drugs for Headache (Chapter 25)
Migraine headache, p. 195-201, Tables 25.1-4
Cluster headache, p. 201, Table 25.5
Medication overuse headache, p. 201
Cycolooxygenase (Cox) Inhibitors: NSAIDs and Acetaminophen (Chapter 57)
Mechanism of action, p. 493, Table 57.1
Classification of Cox inhibitors, p. 493, Table 57.1
First generation NSAIDs, p. 493-99, Tables 57.3-4
Second generation NSAIDs (Cox-2 inhibitors, Coxibs), p. 500
Acetaminophen, p. 500-02, Fig. 57.1
American Heart Association Statement on Cox inhibitors in chronic pain, p. 502-03
Glucocorticoids in Nonendocrine Disorders (Chapter 58)
Review of glucocorticoid physiology, p. 504-05, Fig. 58.1
Pharmacology of the glucocorticoids, p. 505-11, Tables 58.1-2
Drug Therapy for Rheumatoid Arthritis (Chapter 59)
Pathophysiology of rheumatoid arthritis, p. 513, Figure 59.1
Overview of therapy, p. 513-14, Fig. 59.2
NSAIDs, p. 514-16, Table 59.1
Glucocorticoids, p. 516-17
Conventional disease-modifying antirheumatic drugs, p. 517-21, Tables 59.2-4
Biologic disease-modifying antirheumatic drugs, p. 521-25, Tables 59.2-5
Targeted disease-modifying antirheumatic drug: Janus kinase inhibitors, p. 525-26
Drug Therapy of Gout (Chapter 60)
Pathophysiology of gout, p. 528
Overview of drug therapy, p. 528, Table 60.1
Drugs for acute gouty arthritis, p. 528-31
Drugs for hyperuricemia (urate-lowering therapy), p. 531-33, Fig. 60.1, Table 60.2
Pharmacologic management of gout, p. 533-36, Fig. 60.2-4
Drugs for Parkinson Disease (Chapter 19)
The pathophysiology underlying motor symptoms, p. 127, Fig. 19.1
Overview of motor symptom management, p. 127-29
Pharmacology of the drugs used for motor symptoms, p. 129-41, Tables 19.1-5, Fig. 19.2-4, Box 19.1
Nonmotor symptoms and their management, p. 141-42
Drugs for Alzheimer Disease (Chapter 20)
Pathophysiology of Alzheimer disease, p. 143, Fig. 20.1
Risk factors and symptoms, p. 143-44, Table 20.1
Drugs for cognitive impairment, p. 144-49, Tables 20.2-3, Fig. 20.2-3
Drugs for Seizure Disorder (Chapter 21)
Generation of seizures, p. 150
Types of seizures, p. 150-51, Table 21.1
How antiseizure drugs work, p. 151-52, Box 21.1
Basic therapeutic considerations, p. 152-55, Table 21.2
Classification of antiepileptic drugs, p. 155, Table 21.3
Traditional antiseizure drugs, p. 155-62, Tables 21.2, 4, Fig 21.1
Newer antiseizure drugs, p. 162-69, Table 21.2
Management of generalized convulsive status epilepticus, p. 169
Use the treatment guidelines/recommendations associated with Workshop 3 as resources for all assignments with focus on the treatment sections.
Workshop Three
Textbook: Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants
3.2 Group Discussion Case Studies
Cardiovascular Case
Lexi-Comp (available via Up-to-Date) or other suitable drug/disease reference.
Suggested treatment guidelines/recommendations for this workshop:
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults:
2014 Evidence Based Guidelines for the Management of High Blood Pressure in Adults (JNC-8): 
2020 International Society of Hypertension Global Hypertension Practice Guidelines: 
Heart Failure
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Atherosclerotic Cardiovascular Disease
2018 ACC Guideline on the Management of Blood Cholesterol
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce ASCVD in Adults
ASCVD Risk Estimator Plus
2014 ACC/AHA Guideline for the Management of Patients with Non-ST-Elevation Coronary Syndromes (Angina/NSTEMI)
2019 ACC/AHA/HRS Focused Update of the 2014 Guideline for Management of Patients with Atrial Fibrillation
Thromboembolic Disorders
2018 CHEST Antithrombotic Therapy for Atrial Fibrillation
2016 Antithrombotic Therapy for VTE Disease – CHEST Guideline and Expert Panel Report
Warfarin monograph